CClinicalTrials.gg
Status unknownNCT05552209Updated Jan 17, 2023

Assessment of the Safety and Performance of Elbow Supports in the Context of Epicondylitis or a Return to Sport After Sprain

An observational study in Epicondylitis and Elbow Sprain, sponsored by Decathlon SE. Status unknown at 4 sites in France. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-01-17.

Sponsored by Decathlon SE · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Decathlon has developed elbowMID500 and elbowSTRAP products which are medical devices that must be positioned around the elbow during sport practice, in order to limit symptoms related to epicondylitis or previous sprains (elbowMID500 only).

The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon elbowMID500 and elbowSTRAP products to demonstrate safety and performance of these devices in a real-world setting.

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Decathlon elbowMID500 and elbowSTRAP devices and support peer-reviewed publications on products performance and safety.

02

Conditions studied

  • Epicondylitis
  • Elbow Sprain
03

In context

Tennis Elbow

284 studies on the registry are indexed under Tennis Elbow; 60 are open to participants now.

This study's planned enrollment of 60 is below the median of 75 across 26 observational studies indexed under Tennis Elbow.

Browse Tennis Elbow studies →

Lead sponsor

Decathlon SE is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Subjects with acute epicondylitis (stage 1 or 2) or a recent mild elbow sprain whose current condition of their elbow allows them to pursue a usual physical activity.

Inclusion criteria

  • Subject is aged ≥ 18 years old
  • Subject has an acute epicondylitis (stage 1 or 2) OR a recent mild elbow sprain
  • Subject performs regular physical activity (minimum of 2 sessions of 10 minutes per week)
  • The current condition of his/her elbow allows the subject to resume usual physical activity
  • Subject has been informed and is willing to sign an informed consent form
  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)
  • Subject is affiliated to the French social security regime

Exclusion criteria

Exclusion Criteria:

  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
  • Subject has worn a support (elbow brace or articulated orthosis) in the last month during his/her sport practice
  • Subject has resumed regular physical activity since his/her recent injury
  • Subject has any medical condition that could impact the study at investigator's discretion
  • Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastane, polyester, elastodiene) • Adult subject to legal protection measure
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Orthosis group 1

    Use of Elbow Mid 500 device during sport practice

    Device: Elbow MID 500

  • Control group 1

    Control group of the Elbow Mid 500 group - no medical device used during sport practice

    Other: Control group Elbow MID 500

  • Orthosis group 2

    Use of Elbow Strap device during sport practice

    Device: Elbow STRAP

  • Control group 2

    Control group of the Elbow Strap group - no medical device used during sport practice

    Other: Control group Elbow STRAP

Interventions

  • DeviceElbow MID 500

    15 patients will be included in this group and will used the medical device Elbow MID 500 during sport practice (at least 2 sport sessions per week), for 6 weeks.

  • OtherControl group Elbow MID 500

    15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device Elbow MID 500), for at least 2 sport sessions per week during 6 weeks.

  • DeviceElbow STRAP

    15 patients will be included in this group and will used the medical device Elbow STRAP during sport practice (at least 2 sport sessions per week), for 6 weeks.

  • OtherControl group Elbow STRAP

    15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device Elbow STRAP), for at least 2 sport sessions per week during 6 weeks.

06

What researchers measure

Primary outcomes

  1. Functional score

    Comparison of the Japanese Elbow Assessment Score System (JOA elbow scale from 0=worst ouctome to 100=best outcome) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model.

    Time frame: Change from Baseline functionnal score at 6 weeks

Secondary outcomes

  1. Confidence level (confidence questionnaire related to physical activity)

    Gap in the confidence level related to physical activity (scale from 0=worst outcome to 100=best outcome), between the baseline and last follow-up visit in each group (orthosis vs control), for each device model

    Time frame: Change from Baseline confidence level at 6 weeks

  2. Elbow pain

    Comparison of elbow pain, assessed through a Numerical Rating Scale (NRS) ranging from 0=best outcome to 10=worst outcome, between the groups (orthosis vs control), for each device model

    Time frame: Change from Baseline elbow pain at 6 weeks

  3. Safety (adverse events)

    Comparison of adverse events rates between the groups (orthosis vs control), for each device model

    Time frame: 6 weeks of follow-up

07

Study locations

2 of 4 sites recruiting
  • Centre Hospitalier de Boulogne sur Mer
    Boulogne-sur-Mer, 62200, France
    Recruiting
  • Centre de rééducation et de balnéothérapie Kinés Faches
    Faches-Thumesnil, 59155, France
    Recruiting
  • Centre Hospitalier Universitaire de Lille
    Lille, 59000, France
    Not yet recruiting
  • Cabinet de kinésithérapie du Belvédère
    Paris, 75019, France
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05552209
Lead sponsor
Decathlon SE
Collaborators
EFOR, France
Responsible party
Sponsor
First posted
Sep 23, 2022
Start date
Sep 21, 2022
Primary completion
Oct 2023 (estimated)
Completion
Oct 2023 (estimated)
Last update
Jan 17, 2023

Study contacts

Jean HEE
Contact
jean.hee@btwin.com
07 64 35 00 45 ext. +33
Sophie TALLON
Contact
stallon@soladis.fr
Valérie WIECZOREK
principal investigator · Centre Hospitalier Universitaire de Lille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion